Semaglutide is available as a weekly subcutaneous injection or as a daily oral tablet
This work was supported by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Young Scientists (B) Grant Number JP15K19036 (SH), JSPS Grant-in-Aid for Young Scientists Grant Number JP19K16271 (SH), Japan Science and Technology Agency (JST) ACT-X Grant Number JPMJAX201A (SH), RIKEN FY2018 Incentive Research Projects (SH), and Naito Grant for female scientists after maternity leave (SH)
Also, in the Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) study, approximately 10 thousand patients with type 2 diabetes and history of CVD or cardiovascular risk factors were randomized to a weekly subcutaneous injection of dulaglutide 1.5 mg or placebo [16]
Its especially important for producing nitric oxide, which widens blood vessels to support blood flow, promoting immune function and aiding cellular communication
This doesnt always make it unsafe, but it requires careful medical supervision
2018 Aug 6;2(8):906-918